Shopping cart $0
Search
EuroMedLab 2025 is a prestigious international congress focused on clinical chemistry and laboratory medicine, held every two years to showcase the latest scientific advancements and technological innovations. The event brings together leading experts, researchers, and companies from around the world to exchange knowledge and present cutting-edge diagnostic solutions. The program features expert lectures, symposia, and exhibitions of the latest laboratory technologies and products. The congress also serves as a key platform for networking and international collaborations in laboratory diagnostics.
What can you look forward to?
Colleagues from TestLine and DiaSource will demonstrate a fully automated CLIA solution on our KleeYa® analyzer, available at our booth. You will also have the chance to explore another cutting-edge technology Microblot-Array, designed for efficient multiplex diagnostics. Its evaluation is effortlessly performed by the Microblot-Array Reader and software, which will also be available for you to explore. Our offering is complemented by proven immunoassay technologies, including RIA, ELISA, antibodies, and antigens, for advanced diagnostics in endocrinology, autoimmunity, and infectious diseases.
BioVendor R&D contributes to the scientific program of the congress with the abstract "Human Uromodulin: Unique Serum Biomarker for Evaluation of Kidney Damage", presenting new insights into kidney disease diagnostics. These findings will be showcased in the poster section throughout the congress.
We hope this has piqued your interest, and we look forward to meeting you in Brussels!
START: 18 \ 05 \ 2025
END: 22 \ 05 \ 2025
BRUSSELS EXPO, Place de Belgique 1, 1020 Brussels, Belgium
Booth #14, Hall 11
More information: www.euromedlab2025brussels.org
Contact us: Barbora Vraná, vrana@biovendor.cz
Get to know epicGEN – next-generation NGS panels for precise genome analysis. The new epicGEN Solid Cancer & MSI Kit is designed for targeted analysis of 42 genes relevant for the diagnostics of solid tumors and the detection of genetic changes (InDel, SNP, CNV and MSI).
Read more
BioVendor Group changes ownership to partner with a healthcare specialist, strengthening its development and expansion capacities in the global diagnostics market.
Read more
From sequencing to artificial intelligence: Trends shaping the future of laboratory diagnostics
Read more
We’re excited to introduce our new GENOVESA website, designed to provide you with seamless access to advanced software solutions.
Read more
While this motto sets the tone for the upcoming MEDICA 2025, it perfectly encapsulated the spirit of this year’s event, which took place in the second week of November in Düsseldorf.
Read more
BioVendor Group introduces the innovative test for the detection of microsatellite instability leverages state-of-the-art NGS technology
Read more
Reveal lactose, fructose, and histamine intolerance with NGS – all in one test.
Read more
Cutting-edge immunological biomarker and its role in managing infections and immune responses
Read more
The 57th ESHG 2024 is behind us, gathering over 4,500 experts in human genetics.
Read more
BioVendor MDx introduces the first commercial NGS assay for the detection of the BCR::ABL1 fusion gene.
Read more
The BioVendor Group CLIA project is in its third year of operation on the market and is successfully establishing itself in prestigious workplaces in the Czech Republic and other markets.
Read more
First impressions of Medlab 2024
Read more
Together under one roof of BioVendor Group again after one year in Düsseldorf.
Read more
The ECCMID conference showcased the latest findings in clinical microbiology and infectious diseases. And BioVendor Group was part of it!
Read more
A major advance in personalized medicine.
Read more
These were the words of Michal Šteffl, Head of International Sales at TestLine, who summed up the participation of BioVendor Group companies at the most important event in the MENA region.
Read more
We introduce to you our comprehensive and fast solution for the analysis of the CFTR gene.
Read more
It is an annual occasion to meet our current business partners and suppliers and make new connections.
Read more
We introduced a new tool for effective endometrial tumor analysis at the Mendel genetics conference.
Read more
BioVendor Group establishes the molecular diagnostic division BioVendor MDx.
Read more
The most important medical fair took place in its usual autumn term from 15 to 18 November 2021 in Düsseldorf, Germany.
Read more
BioVendor developed user friendly diagnostic NGS kits with excellent analytical parameters and extremely fast processing for laboratories of any size.
Read more
BioVendor Group becomes the exclusive distributor of innovative tests to detect testicular cancer.
Read more
Introducing the CLIA solution from BioVendor Group – an attractive portfolio of parameters, finely-tuned automation, new diagnostic possibilities.
Read more
The prestigious Medlab Middle East 2021 show took place in Dubai from 21st to 24th June, and we couldn't miss it.
Read more
Fully automated CLIA solution with diagnostic parameters from BioVendor Group
Read more
Introducing the new BioVendor Group identity!
Read more
TEAMS internet platform
BioVendor is a proud member of strong academic-industrial consortium focused on research and development in the field of non-coding RNA diagnostics in oncology!
Read more
BioVendor is a proud member of a unique research cluster for the treatment of stroke
Read more
We have established a new product segment within the BioVendor portfolio covering covid-19 relevant products.
Read more
We continue to manufacture and supply in an unchanged manner!
Read more
BioVendor was a part of the largest attended laboratory expo worldwide.
Read more
Now we are getting closer to our goal - translating miRNA biomarkers from research to clinical diagnostics!
Read more
A succesful exhibition at MEDICA attracted many visitors and business partners.
Read more
BioVendor researchers evaluate “Clinical Utility of Current microRNA Detection Methods” in a BioTechniques journal article.
Read more
We are pleased to announce that we have successfully participated in the External Quality Assessment (Referenzinstitut für Bioanalytik, survey of March 2019), being involved in determination of IL-6.
Read more
We are so proud that BioVendor's ANGPTL3 Human ELISA participated in a major study.
Read more
Great pleasure! We thank all who attended BioVendor seminar where MiRXES introduced GASTROClear, a diagnostic microRNA panel for Gastric cancer screening.
Read more
We are pleased to announce that we have successfully participated in the External Quality Assessment (INSTAND, survey of March 20, 2019), being involved in determination of Cystatin C.
Read more
We would like to invite you to a one-day expert seminar organized in cooperation with MiRXES on May 13, 2019.
Read more
BioVendor held distributor meeting in Brno with tour the laboratories and visiting unique Mendel Museum & Augustinian Abbey in Brno.
Read more
Great to see everyone at 9th Gene Quantification Event in Freising-Weihenstephan.
Read more
BioVendor was a part of the largest attended laboratory expo worldwide.
Read more
3rd Annual distributor meeting of BioVendor Group was in a new format this year.
Read more
A succesful exhibition at MEDICA attracted many visitors and business partners.
Read more
BioVendor was a part of the AACC congress in Chicago, USA.
Read more
We will introduce BioVendor original miREIA method for microRNA quantification at the Harvard Medical School soon.
Read more
Within the framework of our continous expansion of IVD products, we are happy to announce that further BioVendor products are now available for IVD use.
Read more
BioVendor was a part of the European Atherosclerosis Society (EAS) congress in Lisbon, Portugal.
Read more
BioVendor was a part of the largest attended laboratory expo worldwide
Read more
A succesful exhibition at MEDICA attracted many visitors and business partners
Read more
We are proud to announce launch of the first miREIA kit.
Read more
miREIA Presented at the AACC 2017, San Diego
Read more